deltatrials
Unknown PHASE2/PHASE3 INTERVENTIONAL 4-arm NCT00111345

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

Multicenter Therapy-Optimization Trial AML-BFM 2004 for the Treatment of Acute Myeloid Leukemias in Children and Adolescents

Sponsor: Deutsche Krebshilfe e.V., Bonn (Germany)

Conditions Myeloid Leukemia
Interventions 2-CDA AI Anthracyclines liposomal daunorubicin
Updated 7 times since 2017 Last updated: May 21, 2012 Started: Mar 31, 2004 Primary completion: Mar 31, 2012 Completion: Mar 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Myeloid Leukemia and is currently ongoing. Deutsche Krebshilfe e.V., Bonn (Germany) leads this study, which shows 7 recorded versions since 2004 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotActive Not Recruiting~May 2017 – ~Jun 2018 · 13 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 9 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2/PHASE3

    Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2_PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2_PHASE3

▶ Show 2 earlier versions

  1. May 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: Active Not Recruiting → Unknown Status

  2. Jan 2017 — May 2017 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Deutsche Krebshilfe e.V., Bonn (Germany)
  • University Hospital Muenster
Data source: University Hospital Muenster

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations